GC
TEVA icon

GFG Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

GFG Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-740
Closed -$12.4K – 314
2025
Q2 		$12.4K Buy
+740
New +$11.9K ﹤0.01% 189

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

GFG Capital's TEVA Position: Q3 2025 in Review

GFG Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2025, closing a stake of 740 shares — an estimated $12.4K sold.

GFG Capital first reported a position in TEVA in Q2 2025 and held it in 1 quarter. The position peaked at $12.4K in Q2 2025. 553 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • GFG Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2025 after selling out during the quarter.
  • GFG Capital sold 740 Teva Pharmaceutical Industries Limited shares in Q3 2025, an estimated $12.4K.
  • GFG Capital first reported a position in Teva Pharmaceutical Industries Limited in Q2 2025 and held it in 1 quarter.
  • GFG Capital's Teva Pharmaceutical Industries Limited position peaked at $12.4K in Q2 2025.
  • 553 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.